On this week's Switzer Show, Peter Switzer talks to:

• Matt Heine, CEO & MD of Netwealth (ASX: NWL) — why a "volume, not seat-based" business is a net winner from AI, the regulation-and-relationships moat a bedroom coder can't replicate, the new Netwealth Private product for high-net-worth clients, and what really drove the share price down.

• Michael Gable, Fairmont Equities — the charts on the S&P 500 and a year of the ASX 200 going sideways, plus buy, hold and avoid calls on Fortescue, Northern Star, James Hardie, Ampol, Wesfarmers, WiseTech, Aristocrat, and his special pick with a fresh buy signal.

• Jacqui Fernley, founder & CIO of arcpoint OCIO — why the first week of US earnings was "a cracker," the one bank number that undercuts the private-credit scare, the chip sell-off as profit-taking rather than collapse, and where oil goes next.

The Switzer Show airs live each Monday at 7pm AEST on switzer.com.au/tv, and streams on Spotify and Apple Podcasts.Nothing in this episode is financial advice. Stocks are discussed for general information only. Consider your own circumstances and seek professional advice before investing.#SwitzerShow #ASX #Netwealth #Investing #AustralianSharesGet a 21-day free trial of the Switzer Report - switzerreport.com.au/subscribeorSubscribe to the free Switzer Daily newsletter - https://switzer.com.au/subscribe

It's a stock market showdown: Paul Rickard of the Switzer Report and Rudi Filapek-Vandyck of FNArena go stock by stock through the market's comeback candidates, calling what they'd buy and what they'd avoid. Plus Peter Switzer opens with what's holding the ASX back: the headwinds now outnumbering the tailwinds, and why he's turning a little more defensive.

- Peter Switzer on the headwinds (the Iran war, rate rises on the table, profit taking) versus the tailwinds, and why he's pulling 80-90% growth portfolios back toward 70%

- NextDC: is the datacentre hype train worth the ride?

- Pro Medicus: what's the prognosis for this health stock?

- Lithium (PLS) and BHP: is it a copper or a dropper?

- PLUS: Bravura Solutions, the Magellan infrastructure play versus its index rivals, and whether the SEMI chip ETF is still worth backing after a huge year

Want every stock call from the show in the guests' own words? Start a 21-day free trial of the Switzer Report: https://www.switzerreport.com.au/subscribe?utm_source=switzertv&utm_medium=referral&utm_campaign=21day-trial

The Switzer Show airs live each Monday at 7pm AEST on switzer.com.au/tv, plus stream on Spotify and Apple Podcasts.

Chapters:

0:00 Intro

0:57 Peter Switzer: what's holding the ASX back

5:10 Paul Rickard and Rudi Filapek-Vandyck join the show

5:57 NextDC (NXT)

11:09 Pro Medicus (PME)

16:15 Lithium and PLS Group (PLS)

22:33 BHP (BHP)

28:06 Bravura Solutions (BVS)

33:33 Magellan Infrastructure Fund (MICH) and the index alternatives

38:36 Global X Semiconductor ETF (SEMI)

Peter Switzer digs into the budget's impact on property, then turns to the healthcare stocks staging a comeback.

First, McGrath founder John McGrath on the negative gearing and capital gains changes, why he calls it the biggest structural shift since capital gains tax arrived, and why he thinks the current correction runs another 6 to 12 months. Then property investing specialists Margaret Lomas (Destiny) and Simon Pressley (Propertyology) on what the changes really mean for investors, why grandfathered negative gearing matters, and the case that Australia is far more than two capital cities. Finally, Adam Dawes of Shaw and Partners on the healthcare rotation, running through CSL, Cochlear, ResMed, Pro Medicus, Telix, Neuren and 4D Medical.

0:00 Intro
1:40 John McGrath (McGrath) on the budget and property
15:25 Margaret Lomas (Destiny) and Simon Pressley (Propertyology)
35:18 Adam Dawes (Shaw and Partners) on the healthcare rotation

Want the full list of stocks our experts rated? Start a 21-day free trial of the Switzer Report: https://www.switzerreport.com.au/subscribe?utm_source=switzertv&utm_medium=referral&utm_campaign=21day-trial

Flight Centre founder Graham 'Skroo' Turner joins Peter Switzer to trace the journey from double-decker bus tours out of 1970s London to a diversified travel business operating in dozens of countries. He talks through COVID's damage, why he once called the internet a passing fad, and where AI itineraries still fall short of a human agent. Turner explains how rising rates and the Middle East conflict are hitting different parts of the business, why corporate travel now drives most of the profit, and why his family bought a large parcel of shares when the price was around $12. He also settles, at last, where the nickname Skroo comes from.

Xero chief executive Sukhinder Singh Cassidy joins Peter Switzer to argue the market's AI sell-off has lumped the wrong companies together. She walks through Xero's latest result (close to NZ$2.7 billion in revenue, growing north of 30% with profit up 18%), why she sees Xero as AI-forward rather than AI-threatened, and what happened when she asked Claude to rebuild Xero from scratch. She also makes the case for the Melio acquisition, Xero's push into bill payments, and how a number-two brand keeps winning share against Intuit in the United States.